The prognostic value of the immunohistochemical expression and mutational pattern of the key mediator of Wnt signaling: Beta-catenin in Tunisian patients with colorectal carcinoma

Applied Immunohistochemistry and Molecular Morphology

Volumn 20, Issue 1, 2012, Pages 62-70

  Khiari, Meriem ^a   Arfaoui, Amira ^a   Kriaa, Lilia ^a   Chaar, Inés ^a   Amara, Sameh ^a   Lounis, Med Amine ^a   Sammoud, Souraya ^a   Dhraeif, Monia ^a   Gharbi, Lassaad ^b   Mzabi Regaya, Sabeh ^a   Bouraoui, Saadia ^a  

^a MONGI SLIM HOSPITAL   (Tunisia)

^b UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

Author keywords

catenin; colorectal carcinomas; E cadherin; exon 3 deletion; immunohistochemistry

Indexed keywords

BETA CATENIN; WNT PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER LOCALIZATION; CANCER PATIENT; CANCER SURVIVAL; CARCINOGENESIS; CELL NUCLEUS; COLORECTAL CARCINOMA; CONTROLLED STUDY; EXON; FEMALE; GENE ACTIVATION; GENE DELETION; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREDICTION; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR DIFFERENTIATION; TUNISIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; BETA CATENIN; CADHERINS; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; EXONS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; RETROSPECTIVE STUDIES; SEQUENCE DELETION; SURVIVAL RATE; TUNISIA; WNT SIGNALING PATHWAY;

EID: 83655167386     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e31821a20c2     Document Type: Article

References (40)

1. Birchmeier W, Weidner KM, HuE lsken J, et al. Molecular mechanisms leading to cell junction (cadherin) deficiency in invasive carcinomas. Semin Cancer Biol. 1993;4:231-239.
2. Ben-Zeev A. The dual role of cytoskeletal anchor proteins in cell adhesion and signal transduction. Ann N Y Acad Sci. 1999;886:37-47.
3. Barth AI, Nathke IS, Nelson WJ. Cadherins, catenins and APC protein: interplay between cytoskeletal complexes and signaling pathways. Curr Opin Cell Biol. 1997;9:683-690. (Pubitemid 27424925)
4. Morin PJ. β-catenin signaling and cancer. BioEssays. 1999;21: 1021-1030.
5. Fujimori M, Ikeda S, Shimizu Y, et al. Accumulation of betacatenin protein and mutations in exon 3 of beta-catenin gene in gastrointestinal carcinoid tumor. Cancer Res. 2001;61:6656-6659. (Pubitemid 32896480)
6. Maruyama K, Ochiai A, Akimoto S, et al. Cytoplasmic beta-catenin accumulation as a predictor of hematogenous metastasis in human colorectal cancer. Oncology. 2000;59:302-309.
7. Ougolkov AV, Yamashita K, Mai M, et al. Oncogenic beta-catenin and MMP-7 (matrilysin) cosegregate in late-stage clinical colon cancer. Gastroenterology. 2002;122:60-71. (Pubitemid 34049195)
8. Miyamoto S, Endoh Y, Hasebe T, et al. Nuclear betacatenin accumulation as a prognostic factor in Dukes D human colorectal cancers. Oncol Rep. 2004;12:245-251.
9. Wong NA, Pignatelli M. b-catenin-a linchpin in colorectal tumorigenesis? Am J Pathol. 2002;160:389-401.
10. Aberle H, Bauer A, Stappert J, et al. b-catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 1997;16:3797-3804.
11. Ikeda S, Kishida S, Yamamoto H, et al. Axin, a negative regulator of the Wnt signalling pathway, forms a complex with GSK-3b-dependent phosphorylation of b-catenin. EMBO J. 1998;17:1371-1384. (Pubitemid 28105516)
12. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science. 1991;251:1451-1455. (Pubitemid 121000430)
13. Ilyas M, Tomlinson IP, Rowan A, et al. b-catenin mutations in cell lines established from human colorectal cancers. Proc Natl Acad Sci U S A. 1997;94:10330-10334. (Pubitemid 27407041)
14. Kim IJ, Kang HC, Park JH, et al. Development and applications of a b-catenin oligonucleotide microarray: b-catenin mutations are dominantly found in the proximal colon cancers with microsatellite instability. Clin Cancer Res. 2003;9:2920-2925. (Pubitemid 36993250)
15. Rubinfeld B, Albert L, Porfiri E, et al. Binding of GSK-3b to the APC-b-catenin complex and regulation of complex assembly. Science. 1996;272:1023-1026. (Pubitemid 26259322)
16. Morin PJ, Sparks AB, Korinek V, et al. Activation of b-catenin- TCF signaling in colon cancer by mutations in b-catenin or APC. Science. 1997;275:1787-1790. (Pubitemid 27136715)
17. Sparks AB, Morin PJ, Vogelstein B, et al. Mutational analysis of the APC/bcatenin/Tcf pathway in colorectal cancer. Cancer Res. 1998;58:1130-1134. (Pubitemid 28183198)
18. Gunther K, Brabletz T, Kraus C, et al. Predictive value of nuclear b-catenin expression for the occurrence of distant metastases in rectal cancer. Dis Colon Rectum. 1998;41:1256-1261. (Pubitemid 28477975)
19. Maruyama K, Ochiai S, Akimoto A, et al. Cytoplasmic b-catenin accumulation as a predictor of hematogenous metastasis in human colorectal cancer. Oncology. 2000;59:302-309.
20. Masaki T, Matsuoka H, Sugiyama M, et al. Matrilysin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas. Br J Cancer. 2001;84:1317-1321. (Pubitemid 32522098)
21. Nelson AR, Fingleton B, Rothenberg ML, et al. Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol. 2000;18:1135-1149. (Pubitemid 30123793)
22. Wong SC, Lo ES, Lee KC, et al. Prognostic and diagnostic significance of b-catenin nuclear immunostaining in colorectal cancer. Clin Cancer Res. 2004;10:1401-1408. (Pubitemid 38365235)
23. Crawford HC, Fingleton BM, Rudolph-Owen LA, et al. The metalloproteinase matrilysin is a target of b-catenin transactivation in intestinal tumour. Oncogene. 1999;18:2883-2891. (Pubitemid 29250878)
24. Lugli A, Zlobec I, Minoo P, et al. Prognostic significance of the Wnt signalling pathway molecules APC, b-catenin and E-cadherin in colorectal cancer: a tissue microarray-based analysis. Histopathology. 2007;50:453-464. (Pubitemid 46328181)
25. Kemler R. From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion. Trends Genet. 1993;9:317-321. (Pubitemid 23271755)
26. Vleminck K, Vakaet L Jr, Mareel M, et al. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell. 1991;66:107-119. (Pubitemid 121001351)
27. Meiners S, Brinkmann V, Naundorf H, et al. Role of morphogenetic factors in metastasis of mammary carcinoma cells. Oncogene. 1998;16:9-20. (Pubitemid 28043504)
28. Schipper JH, Frixen UH, Behrens J, et al. E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dediVerentiation and lymph node metastasis. Cancer Res. 1991;51:6328-6337.
29. Mayer B, Johnson JP, Leitl F, et al. E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dediVerentiation and glandular disintegration. Cancer Res. 1993;53:1690-1695. (Pubitemid 23113253)
30. Umbas R, Schalken JA, Aalders TW, et al. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in highgrade prostate cancer. Cancer Res. 1992;52:5104-5109.
31. Oka H, Shiozaki H, Kobayashi K, et al. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res. 1993;53:1696-1701. (Pubitemid 23113254)
32. Elzagheid A, Ålgars A, Bendardaf R, et al. E-cadherin expression pattern in primary colorectal carcinomas and their metastases reflects disease outcome. World J Gastroenterol. 2006;12: 4304-4309. (Pubitemid 44194521)
33. Iwao K, Nakamori S, Kameyama M, et al. Activation of the b-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations. Cancer Res. 1998;58:1021-1026. (Pubitemid 28182473)
34. Murata M, Iwao K, Miyoshi Y, et al. Activation of the b-catenin gene by interstitial deletions involving exon 3 as an early event in colorectal tumorigenesis. Cancer Lett. 2000;159: 73-78.
35. Ikeda S, Kishida M, Matsuura Y, et al. GSK-3 b-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by b-catenin and protein phosphatase 2A complexed with axin. Oncogene. 2000;19:537-545. (Pubitemid 30099367)
36. Masahiko F, Satoshi I, Yosuke S, et al. Accumulation of β-catenin protein and mutations in exon 3 of β-catenin gene in gastrointestinal carcinoid tumor. Cancer Res. 2001;61:6656-6659.
37. Bougatef K, Ouerhani S, Moussa A, et al. Prevalence of mutations in APC, CTNNB1, and BRAF in Tunisian patients with sporadic colorectal cancer. Cancer Genet Cytogenet. 2008;187:12-18.
38. Miyoshi Y, Iwao K, Nawa G, et al. Frequent mutations in the b-catenin gene in desmoid tumors from patients without familial adenomatous polyposis. Oncol Res. 1998;10:591-594. (Pubitemid 128740447)
39. Behrens J, Jerchow BA, Wuertele M, et al. Functional interaction of an axin homolog, conductin, with β-catenin, APC, and GSK-3β. Science. 1998;280:596-599.
40. Nelson WJ, Nusse R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science. 2004;303:1483-1487. (Pubitemid 38314410)